Antimicrobials: The Year in Review

News
Article

This year saw the approval of new therapies as well as the continued evolution of time-to-treat infections and updated guidelines.

Recent Videos
Related Content
Greater Incidence of Antimicrobial Resistant Infections in Cancer Outpatients

Greater Incidence of Antimicrobial Resistant Infections in Cancer Outpatients

John Parkinson
May 13th 2025
Article
From Pathogen to Infectious Disease Diagnosis: Test Determines Between Bacterial and Viral Infections in 15 Minutes

From Pathogen to Infectious Disease Diagnosis: Test Determines Between Bacterial and Viral Infections in 15 Minutes

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc ;Eran Eden, PhD
April 14th 2025
Podcast
Wiki-What? Navigating WikiGuidelines and Leveraging Their Advantages

Wiki-What? Navigating WikiGuidelines and Leveraging Their Advantages

Brent Footer, PharmD, BCIDP;Mira Maximos, PharmD, MSc, ACPR;Alyssa B. Christensen, PHARMD, BCIDP
May 7th 2025
Article
Identifying Invasive Pneumococci in Pediatric Infections Utilizing Whole Genome Sequencing

Identifying Invasive Pneumococci in Pediatric Infections Utilizing Whole Genome Sequencing

Jose Alexander, MD, ABMM, ABAIM, FCCM, CIC, ASCP, BCMAS;Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
March 24th 2025
Podcast
When Should We De-Escalate Empiric Antimicrobials?

When Should We De-Escalate Empiric Antimicrobials?

Caitlin Hart, PharmD ;Lauren R. Biehle, PharmD, BCPS, BCIDP;Meghan N. Jeffres, PharmD, BCIDP
May 6th 2025
Article
Addressing Gram-Negative Infections With Further Insights From Cefiderocol's PROVE Study

Addressing Gram-Negative Infections With Further Insights From Cefiderocol's PROVE Study

John Parkinson
May 5th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.